Navigation Links
Hahnemann University Hospital Receives Approval From The Commission on Cancer
Date:4/3/2009

PHILADELPHIA, April 3 /PRNewswire-USNewswire/ -- The Cancer Center at Hahnemann University Hospital has been granted a Three-Year Approval with Commendation by The Commission on Cancer (CoC) of the American College of Surgeons (ACoS).

The Cancer Center at Hahnemann received the approval following an on-site evaluation by a physician surveyor. Approval by the CoC is awarded only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and that undergo a rigorous evaluation process and review of their performance. Receiving care at a CoC-approved cancer program ensures that a patient will have access to:

  • Comprehensive care, including a range of state-of-the-art services and equipment
  • A multispecialty, team approach to coordinate the best treatment options
  • Information about ongoing clinical trials and new treatment options
  • Access to cancer-related information, education, and support
  • A cancer registry that collects data on type and stage of cancers and treatment results and offers lifelong patient follow-up
  • Ongoing monitoring and improvement of care
  • Quality care close to home

"The Cancer Center at Hahnemann provides high quality care by taking a unique multidisciplinary approach. The Cancer Center offers a wide range of services to help patients both physically and emotionally over their course of treatment," stated Michael P. Halter, FACHE, chief executive officer of Hahnemann University Hospital.

Approximately 25 percent of hospitals in America and Puerto Rico that treat cancer patients have received the approval award from the Commission on Cancer. Despite only representing a quarter of hospitals nationwide, CoC-accredited hospitals diagnose and/or treat 80 percent of newly diagnosed cancer patients each year.

About Hahnemann University Hospital

Hahnemann University Hospital is a 541-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city's first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia's first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation's oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher's Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com


'/>"/>
SOURCE Hahnemann University Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hahnemann University Hospital and St. Christophers Hospital for Children Receive Prestigious Tenet Circle of Excellence Award
2. Hahnemann University Hospital and St. Christophers Hospital for Children Extend Current Agreement With Independence Blue Cross
3. Hospital Workers Ratify Contract With Hahnemann
4. University of Iowa professor identifies new eating disorder
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
7. Tulane University to receive $14M for international HIV/AIDS program
8. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
9. Boston University School of Medicine researcher recipient of Memory Ride Grant
10. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
11. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... Bellus Medical, a leader in medical aesthetics, ... In his new role Dr. Dobke will provide physician oversight for in-house clinical studies ... Head of Plastic Surgery and Associate Professor of Surgery at UC San Diego Health ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical economic ... the Frank Hawkins Kenan Institute of Private Enterprise at the University ... makers identified concrete solutions at the “What’s Next, America?” conference at the Kenan ...
(Date:1/24/2017)... Rosa, CA (PRWEB) , ... January 24, 2017 , ... ... is good news for everyone and particularly good news for prostate cancer patients: incidents ... the diagnosis. , According to the report the cancer death rate has dropped from ...
(Date:1/24/2017)... ... ... American Family Care (AFC) has opened a new 4,000+ square foot state-of-the-art urgent ... area. The Bedford clinic will be the nineteenth location opened by AFC in Massachusetts ... Dr. Kristina Orio. Adams and Orio also independently own and operate AFC clinics in ...
(Date:1/24/2017)... ... January 24, 2017 , ... TopConsumerReviews.com recently ... relieving premenstrual syndrome, or PMS . , Most women of child-bearing age ... include cramps, constipation, irritability, headaches, fatigue, and other discomfort. For some women, ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Research and Markets has announced the addition of the ... - Forecast to 2025" report to their offering. ... The Global Implantable Medical ... 5.4% over the next decade to reach approximately $54.28 billion by ... is witnessing include 3D medical printing is expected to develop and ...
(Date:1/24/2017)... GAITHERSBURG, Md. , Jan. 24, 2017 /PRNewswire/ ... leader in the engineering and industrialization of biology to improve ... announced that it has entered into a definitive agreement to ... a clinical-stage company and pioneer in the development of AdenoVerse™ ... and expand upon GenVec,s expertise in adenoviral vectors and cGMP ...
(Date:1/24/2017)... 24, 2017   QR Pharma , Inc., ... novel therapies for the treatment of Alzheimer,s, Parkinson,s ... of four world-class key opinion leaders to its ... QR Pharma,s previous roster of impressive advisors in ... support the development of the breakthrough mechanism of ...
Breaking Medicine Technology: